No BS Just Facts logo
No BS Just Facts
It might be boring, but it's just the facts.

← All stories · business

Bloomberg

Lilly Buying Spree Surpasses $32B

Wednesday, November 18, 2026


Eli Lilly agreed to acquire Calytrix Bio in a deal valued at up to 1.5 billion dollars, according to Bloomberg. The acquisition is part of Lilly's broader spending on deals totaling 32 billion dollars in 2026. Lilly has stated it is using the acquisitions to expand its cancer and immunology businesses.

Original reporting:

Next story

Kim Jong Un's nuclear buildup sparks 'serious concern' ahead of Trump-Xi-Putin summit→